• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT在原发性肺淋巴瘤患者中的作用。

Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.

作者信息

Peng Ying, Qi Wanling, Luo Zhehuang, Zeng Qingyun, Huang Yujuan, Wang Yulu, Sharma Amit, Schmidt-Wolf Ingo G H, Liao Fengxiang

机构信息

Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.

Department of Nuclear Medicine, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.

出版信息

Front Oncol. 2022 Sep 14;12:973109. doi: 10.3389/fonc.2022.973109. eCollection 2022.

DOI:10.3389/fonc.2022.973109
PMID:36185301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9515576/
Abstract

BACKGROUND

Primary pulmonary lymphoma (PPL) is defined as clonal abnormal hyperplasia of lung parenchyma or bronchial lymphoid tissue originating from bronchial mucosal tissue. However, PPL is rare, which accounts for approximately 3-4% of extraneurotic lymphomas and 0.5-1% of all primary tumors in the lung. Owing to the lack of any typical clinical symptoms and radiological features, it is challenging to accurately diagnose PPL, which affects its clinical management and prognosis. Considering this, herein, we aim to raise awareness of this disease and help physicians understand the role of 18F-FDG PET/CT in the diagnosis of PPL.

METHOD

A retrospective analysis was performed on the clinical and 18F-FDG PET/CT imaging data of 19 patients diagnosed with PPL by biopsy pathology at our hospital from April 2014 to December 2021.

RESULTS

Of the 19 PPL patients, 15 patients showed clinical symptoms with the most common being fever and cough. In addition, there were 4 cases that had no clinical symptoms, and all of them were MALT lymphoma. In fact, 16 patients were misdiagnosed as lobar pneumonia, lung cancer, tuberculosis, and diffuse interstitial inflammation, representing a misdiagnosis rate of 84.2%. Also, 73.7% were MALT lymphomas, representing the most common pathological pattern, along with 3 DLBCL and 2 T-cell lymphomas. With reguard to CT signs, the air-bronchial sign was found to be the most common, followed by the halo sign and the collapsed leaf sign. On the basis of the predominant radiologic features, lesions were categorized as pneumonic consolidation, nodular/mass type, diffuse interstitial type, and mixed type. The average SUVmax of lesions was 7.23 ± 4.75, the ratio of SUVmax (lesion/liver) was 3.46 ± 2.25, and the ratio of SUVmax (lesion/mediastinal blood pool) was found to be 5.25 ± 3.27. Of interest, the different pathological types of PPL showed different values of 18F-FDG uptake. The 18F-FDG uptake of DLCBL was the most prominent with a SUVmax of 15.33 ± 6.30 and was higher than that of MALT lymphoma with a SUVmax of 5.74 ± 2.65. There appeared similarity in 18F-FDG uptake between MALT lymphoma and T-cell lymphoma. For the SUVmax of lesion, we found statistical significance between MALT lymphoma and DLCBL (P value<0.001). In addition, we also found statistical significance (P value < 0.05) in SUVmax of lesions between pneumonic consolidation type and nodal/mass type, I stage, and other stages.

CONCLUSIONS

On 18F-FDG PET/CT images, certain features of PPL morphology and metabolism can be identified that may contribute to a better understanding of this disease. In addition, 18F-FDG PET/CT whole-body imaging has the potential to refine the staging of PPL. Most importantly, functional 18F-FDG PET/CT imaging can readily reflect tumor cell activity, thus allowing for the selection of an optimal biopsy site.

摘要

背景

原发性肺淋巴瘤(PPL)被定义为起源于支气管黏膜组织的肺实质或支气管淋巴组织的克隆性异常增生。然而,PPL较为罕见,约占结外淋巴瘤的3 - 4%,占所有原发性肺部肿瘤的0.5 - 1%。由于缺乏任何典型的临床症状和影像学特征,准确诊断PPL具有挑战性,这影响了其临床管理和预后。考虑到这一点,在此我们旨在提高对该疾病的认识,并帮助医生了解18F - FDG PET/CT在PPL诊断中的作用。

方法

对2014年4月至2021年12月在我院经活检病理确诊为PPL的19例患者的临床及18F - FDG PET/CT影像资料进行回顾性分析。

结果

19例PPL患者中,15例有临床症状,最常见的是发热和咳嗽。此外,有4例无临床症状,均为黏膜相关淋巴组织(MALT)淋巴瘤。实际上,16例患者被误诊为大叶性肺炎、肺癌、肺结核和弥漫性间质性炎症,误诊率为84.2%。同时,73.7%为MALT淋巴瘤,是最常见的病理类型,还有3例弥漫大B细胞淋巴瘤(DLBCL)和2例T细胞淋巴瘤。关于CT征象,空气支气管征最常见,其次是晕征和肺叶萎陷征。根据主要影像学特征,病变分为肺炎实变型、结节/肿块型、弥漫间质型和混合型。病变的平均最大标准摄取值(SUVmax)为7.23±4.75,SUVmax(病变/肝脏)比值为3.46±2.25,SUVmax(病变/纵隔血池)比值为5.25±3.27。有趣的是,不同病理类型的PPL显示出不同的18F - FDG摄取值。DLBCL的18F - FDG摄取最显著,SUVmax为15.33±6.30,高于MALT淋巴瘤的SUVmax(5.74±2.65)。MALT淋巴瘤和T细胞淋巴瘤在18F - FDG摄取方面表现出相似性。对于病变的SUVmax,我们发现MALT淋巴瘤和DLBCL之间具有统计学意义(P值<0.001)。此外,我们还发现肺炎实变型与结节/肿块型、Ⅰ期和其他期之间病变的SUVmax也具有统计学意义(P值<0.05)。

结论

在18F - FDG PET/CT图像上,可以识别出PPL形态和代谢的某些特征,这可能有助于更好地理解该疾病。此外,18F - FDG PET/CT全身成像有潜力完善PPL的分期。最重要的是,功能性18F - FDG PET/CT成像能够很容易地反映肿瘤细胞活性,从而有助于选择最佳活检部位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/863a14aac3f6/fonc-12-973109-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/a3704abd3c2d/fonc-12-973109-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/7c6413c72b45/fonc-12-973109-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/6a826dda1b2e/fonc-12-973109-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/863a14aac3f6/fonc-12-973109-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/a3704abd3c2d/fonc-12-973109-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/7c6413c72b45/fonc-12-973109-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/6a826dda1b2e/fonc-12-973109-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af99/9515576/863a14aac3f6/fonc-12-973109-g004.jpg

相似文献

1
Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.18F-FDG PET/CT在原发性肺淋巴瘤患者中的作用。
Front Oncol. 2022 Sep 14;12:973109. doi: 10.3389/fonc.2022.973109. eCollection 2022.
2
[Clinical Analysis of Pulmonary Lymphoma].[肺淋巴瘤的临床分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):109-114. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.017.
3
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.18F-FDG PET/CT在胃黏膜相关淋巴组织淋巴瘤中的应用:一项双中心研究经验
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):589-597. doi: 10.1007/s00259-016-3518-y. Epub 2016 Sep 12.
4
The role of baseline 2-[ F]-FDG-PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis.基线 2-[F]-FDG-PET/CT 指标和放射组学特征在预测原发性胃淋巴瘤诊断中的作用。
Hematol Oncol. 2024 Mar;42(2):e3266. doi: 10.1002/hon.3266.
5
HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?原发性肺淋巴瘤的高分辨率计算机断层扫描(HRCT):CT成像表型能否区分黏膜相关淋巴组织(MALT)淋巴瘤和非MALT淋巴瘤的组织学亚型?
J Thorac Dis. 2018 Nov;10(11):6040-6049. doi: 10.21037/jtd.2018.10.63.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
18F-FDG PET/CT in primary brain lymphoma.18F-FDG PET/CT 在原发性脑淋巴瘤中的应用。
J Neurooncol. 2018 Feb;136(3):577-583. doi: 10.1007/s11060-017-2686-3. Epub 2017 Nov 17.
8
Pulmonary mucosa-associated lymphoid tissue lymphoma: F-FDG PET/CT and CT findings in 28 patients.肺黏膜相关淋巴组织淋巴瘤:28例患者的F-FDG PET/CT及CT表现
Br J Radiol. 2017 Nov;90(1079):20170311. doi: 10.1259/bjr.20170311. Epub 2017 Oct 3.
9
Correlation between F-FDG PET/CT semiquantitative parameters and Ki-67 expression in pulmonary mucosa-associated lymphoid tissue lymphoma.F-FDG PET/CT半定量参数与肺黏膜相关淋巴组织淋巴瘤中Ki-67表达的相关性
J Med Imaging Radiat Oncol. 2021 Apr;65(2):188-194. doi: 10.1111/1754-9485.13146. Epub 2021 Feb 3.
10
18F-FDG PET/CT in splenic marginal zone lymphoma.18F-FDG PET/CT 在脾边缘区淋巴瘤中的应用。
Abdom Radiol (NY). 2018 Oct;43(10):2721-2727. doi: 10.1007/s00261-018-1542-z.

引用本文的文献

1
Rare Case Report of Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma.肺黏膜相关淋巴组织淋巴瘤罕见病例报告
Respirol Case Rep. 2025 Aug 26;13(8):e70284. doi: 10.1002/rcr2.70284. eCollection 2025 Aug.
2
Surgical management of stage IE/IIE primary pulmonary lymphomas: a propensity score matching study.ⅠE/ⅡE期原发性肺淋巴瘤的外科治疗:一项倾向评分匹配研究
J Thorac Dis. 2025 Jan 24;17(1):134-149. doi: 10.21037/jtd-24-1524. Epub 2025 Jan 22.
3
Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.

本文引用的文献

1
The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future.既往肺结核与未来肺癌风险之间的关系。
Infect Agent Cancer. 2022 May 7;17(1):20. doi: 10.1186/s13027-022-00434-2.
2
Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review.50 例原发性肺淋巴瘤的临床分析:回顾性研究及文献复习。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221075529. doi: 10.1177/15330338221075529.
3
Clinical Features and Surgical Treatment of Primary Pulmonary Lymphoma: A Retrospective Study.
发现大麻二酚的单一或与细胞因子诱导的杀伤细胞联合的抗肿瘤作用对非小细胞肺癌细胞的影响。
Front Immunol. 2024 Mar 14;15:1268652. doi: 10.3389/fimmu.2024.1268652. eCollection 2024.
4
Pulmonary extranodal natural killer/T-cell lymphoma: clinical presentation, CT characteristics, and patient outcomes.肺结外自然杀伤细胞/ T细胞淋巴瘤:临床表现、CT特征及患者预后
Quant Imaging Med Surg. 2023 Dec 1;13(12):8358-8369. doi: 10.21037/qims-23-365. Epub 2023 Nov 9.
5
Evaluation of CT features for differentiating consolidation pattern of pulmonary MALT lymphoma from pneumonic-type lung adenocarcinoma.CT特征对鉴别肺黏膜相关淋巴组织淋巴瘤实变模式与肺炎型肺腺癌的评估
Front Oncol. 2023 Sep 1;13:1234291. doi: 10.3389/fonc.2023.1234291. eCollection 2023.
6
Primary pulmonary lymphoma in Peru.秘鲁的原发性肺淋巴瘤。
Ecancermedicalscience. 2023 Jun 15;17:1559. doi: 10.3332/ecancer.2023.1559. eCollection 2023.
7
Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors.修订肺癌细胞因子诱导的杀伤细胞治疗领域:聚焦免疫检查点抑制剂。
Int J Mol Sci. 2023 Mar 15;24(6):5626. doi: 10.3390/ijms24065626.
8
Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma.睾丸癌原发性肺核蛋白的临床影像学表现。
Front Med (Lausanne). 2023 Jan 4;9:1083206. doi: 10.3389/fmed.2022.1083206. eCollection 2022.
9
Primary pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: a case report and literature review.原发性肺黏膜相关淋巴组织型结外边缘区B细胞淋巴瘤:1例报告及文献复习
Am J Transl Res. 2022 Dec 15;14(12):9072-9077. eCollection 2022.
原发性肺淋巴瘤的临床特征与外科治疗:一项回顾性研究
Front Oncol. 2022 Feb 3;12:779395. doi: 10.3389/fonc.2022.779395. eCollection 2022.
4
A retrospective study on the clinical characteristics and radiological features of primary pulmonary lymphoma.原发性肺淋巴瘤临床特征及影像学表现的回顾性研究
Transl Cancer Res. 2020 Mar;9(3):1969-1977. doi: 10.21037/tcr.2020.02.16.
5
Comparison between the molecular diagnostic test and chest X-ray combined with multi-slice spiral CT in the diagnosis of lobar pneumonia.分子诊断检测与胸部 X 射线联合多层螺旋 CT 在肺叶性肺炎诊断中的比较。
Cell Mol Biol (Noisy-le-grand). 2021 Nov 25;67(3):129-132. doi: 10.14715/cmb/2021.67.3.18.
6
Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma.原发性肺淋巴瘤的临床病理特征及预后因素
J Thorac Dis. 2021 Feb;13(2):1106-1117. doi: 10.21037/jtd-20-3159.
7
Primary Pulmonary MALT Lymphoma: A Case Report and Literature Review.原发性肺黏膜相关淋巴组织淋巴瘤:一例报告及文献复习
Biomed Hub. 2019 Sep 24;4(3):1-5. doi: 10.1159/000502488. eCollection 2019 Sep-Dec.
8
Comparison of radiologic characteristics and pathological presentations of primary pulmonary lymphoma in 22 patients.22例原发性肺淋巴瘤的放射学特征与病理表现比较
J Int Med Res. 2020 Apr;48(4):300060519879854. doi: 10.1177/0300060519879854. Epub 2019 Dec 27.
9
Evaluation of the diagnostic efficacy of F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country.评估 F-氟代-2-脱氧-D-葡萄糖 PET/CT 对结核病高发国家肺癌和肺结核的诊断效能。
Cancer Med. 2020 Feb;9(3):931-942. doi: 10.1002/cam4.2770. Epub 2019 Dec 13.
10
Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa-associated lymphoid tissue-derived lymphoma.肺黏膜相关淋巴组织淋巴瘤的临床特征、诊断、治疗和预后因素。
Cancer Med. 2019 Dec;8(18):7660-7668. doi: 10.1002/cam4.2683. Epub 2019 Nov 5.